Companies /Basic Materials
Celanese Corp - Series A
NYSE: CE Chemicals
$44.73
▲ $0.17 (+0.38%) today
Markets closed · 8:24am ET

Celanese (CE) Q3 2025 Earnings

Reported Nov 6, 2025, 4:25pm ET · SEC source
$1.34
Beat +9.59%
EPS · est. $1.22
$2.4B
Miss −3.71%
Revenue · est. $2.5B
+2.3%
Beating market
CE vs S&P since report
1 quarter
Consecutive EPS beats

How Did CE Stock React to Q3 2025 Earnings?

% change · around the report
−10%−5%0+5%Nov 6Nov 7report 4:25pm ETearnings+0.1%+4.7%
−10%−5%0+5%Nov 6Nov 7earnings+0.1%+4.7%
CE +4.7%S&P 500 +0.1%
−10%−5%0+5%Nov 6Nov 7report 4:25pm ETearnings−0.3%+4.7%
−10%−5%0+5%Nov 6Nov 7earnings−0.3%+4.7%
CE +4.7%NASDAQ −0.3%
−5%0+5%Nov 5Nov 14report 4:25pm ETearnings+0.1%−0.2%
−5%0+5%Nov 5Nov 14earnings+0.1%−0.2%
CE −0.2%S&P 500 +0.1%
−5%0+5%Nov 5Nov 14report 4:25pm ETearnings−0.5%−0.2%
−5%0+5%Nov 5Nov 14earnings−0.5%−0.2%
CE −0.2%NASDAQ −0.5%
+14.37%
Day of report
−0.02%
Next session
−5.71%
One week
+4.75%
30 days

S&P 500 over the same 30 days: +2.47%.

Did CE Beat Earnings? Q3 2025 Results

Yes. Celanese reported Q3 2025 earnings of $1.34 a share on Nov 6, 2025, beating the $1.22 consensus estimate by 9.6%. Revenue was $2.4B against a $2.5B estimate.

Celanese delivered a mixed Q3 2025, posting adjusted EPS of $1.34 against a consensus estimate of $1.22, a beat of 9.59%, even as revenue of $2.42 billion fell short of the $2.51 billion analysts expected and declined 8.7% year-over-year amid persistent demand weakness across most end-markets. The headline GAAP results were dominated by $1.49 billion in non-cash asset impairment charges, including significant goodwill and trade name writedowns in the Engineered Materials segment, underscoring the difficult operating environment the specialty chemicals maker continues to navigate. A standout bright spot was free cash flow of $375 million, a sharp recovery from negative free cash flow in the year-ago period, fueled by cost reductions and inventory drawdowns. The company also signed a definitive agreement to divest its Micromax® portfolio for approximately $500 million, with proceeds earmarked for debt reduction. Looking ahead, management guided Q4 adjusted EPS to $0.85 to $1.00, reflecting typical western hemisphere seasonality, while targeting full-year 2025 free cash flow of $700 million to $800 million as deleveraging remains the central strategic priority.

Key Takeaways
  • Cost reduction programs targeting discretionary spend, SG&A, and logistics/distribution
  • Product mix enrichment through High Impact Programs (HIPs) emphasizing specialty offerings
  • Inventory reduction of approximately $100 million targeted in Engineered Materials for 2025
  • Production optimization at low-cost U.S. based assets with reduced operating rates at higher cost sites

“Our strong third quarter free cash flow and Micromax® divestiture announcement clearly demonstrate that we are executing against our strategic action plans. Our third quarter free cash flow performance is a substantial improvement over the same period last year and shows the robust cash generation capabilities we have and continue to utilize. The signing of the Micromax® divestiture demonstrates our commitment to aggressively and prudently taking steps to deleverage our balance sheet. I thank our teams for their tenacity and resilience in driving these outcomes.”

Celanese CEO, on the earnings call

What Was Celanese's Outlook in Q3 2025?

Celanese expects Q4 2025 volume declines due to western hemisphere seasonality, partially offset by continued cost reduction efforts. Q4 2025 adjusted EPS is guided to $0.85 to $1.00. Full-year 2025 free cash flow is expected in the range of $700 to $800 million. The company remains focused on generating cash to accelerate deleveraging, intensifying cost improvements, and driving top-line growth, with the Micromax® divestiture expected to close in Q1 2026 and proceeds directed to debt reduction.

CE YoY Financials

Q3 2025 vs Q3 2024 · SEC filings Q3 2024 Q3 2025
$0$800.0M$1.6B$2.4B$2.6B$2.4BRevenue$622.0M$521.0MGross Profit
$0$800.0M$1.6B$2.4BRevenueGross Profit
CE income statement, Q3 2025 versus Q3 2024
Metric Q3 2025 Q3 2024 Year over year
Revenue $2.4B $2.6B −8.7%
Gross Profit $521.0M $622.0M −16.2%

CE Revenue by Segment

Engineered Materials$1.4B
Acetyl Chain$1.1B

Figures from SEC filings and company reports. Not investment advice.